News
People regularly exposed to ‘forever chemicals’ are at greater risk of developing type 2 diabetes compared to those rarely ...
A new study published in The New England Journal of Medicine showed that daily dapagliflozin dramatically reduced the risk of ...
A randomized controlled trial investigated use of sodium glucose cotransporter 2 inhibitors (SGLT2i) on top of standard care immunosuppression in lupus nephritis.
Adults who feel anxious on a Monday have greater long-term stress hormone levels, regardless of their working status, new research has highlighted. A recent study from the University of Hong Kong has ...
The Maryland Prescription Drug Affordability Board (PDAB) found that Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin) present affordability ...
AstraZeneca posted $14.46 billion in Q2 revenue, reaffirming its 2025 outlook as the FDA advances Imfinzi in gastric cancer.
5d
MedPage Today on MSNCaution Advised With Upfront SGLT2 Inhibitor-MRA Combo for Heart FailureIncluded in the open-label crossover SOGALDI-PEF study were adults with symptomatic heart failure (New York Heart Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results